The company maintains a precarious capital structure with a negative equity position of $2.8 billion and a rising debt load that has increased from $4.7 billion in 2024Q2 to $8.9 billion in 2026Q3.
| Metric | TTM | Jun'25 | Jun'24 | Jun'23 | Jun'22 | Jun'21 | Jun'20 | Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 | Jun'10 | Jun'09 | Jun'08 | Jun'07 | Jun'06 | Jun'05 | Jun'04 | Jun'03 | Jun'02 | Jun'01 | Jun'00 | Jun'99 | Jun'98 | Jun'97 | Jun'96 |
|---|
| Total Current Assets | 38.06B | 36.37B | 34.88B | 33.74B | 32.94B | 31.05B | 25.94B | 25.75B | 24.55B | 28.34B | 21.96B | 21.75B | 17.94B | 17.77B | 17.51B | 16.32B | 14.92B | 20.98B | 14.28B | 14.54B | 16.58B | 13.53B | 13.06B | 13.25B | 11.91B | 10.72B | 8.45B | 5.2B | 4.79B | 2.49B | 2.34B |
| Cash & Short-Term Investments | 3.94B | 3.87B | 5.13B | 4.08B | 4.72B | 3.41B | 2.77B | 2.53B | 1.76B | 6.88B | 2.36B | 4.62B | 2.87B | 1.9B | 2.27B | 1.93B | 2.76B | 1.22B | 1.68B | 1.44B | 1.69B | 1.5B | 1.1B | 1.72B | 1.38B | 934.1M | 539.5M | 185.4M | 373.3M | 243.1M | 304.3M |
| Cash Only | 3.94B | 3.87B | 5.13B | 4.08B | 4.72B | 3.41B | 2.77B | 2.53B | 1.76B | 6.88B | 2.36B | 4.62B | 2.87B | 1.9B | 2.27B | 1.93B | 2.76B | 1.22B | 1.29B | 1.31B | 1.19B | 1.4B | 1.1B | 1.72B | 1.38B | 934.1M | 539.5M | 185.4M | 373.3M | 243.1M | 304.3M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 383.7M | 132M | 498.4M | 99.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 13.65B | 13.24B | 12.08B | 11.11B | 10.56B | 9.1B | 8.26B | 8.45B | 7.8B | 8.05B | 7.41B | 6.52B | 5.38B | 6.3B | 6.36B | 6.16B | 5.17B | 5.21B | 4.99B | 4.71B | 3.81B | 3.1B | 3.43B | 2.78B | 2.3B | 2.41B | 2.4B | 1.6B | 1.44B | 672.2M | 612.3M |
| Days Sales Outstanding | 19.78 | 21.72 | 19.45 | 19.78 | 21.26 | 20.45 | 19.72 | 21.19 | 20.81 | 22.6 | 22.24 | 23.22 | 21.56 | 22.76 | 21.57 | 21.89 | 19.16 | 19.83 | 20.83 | 19.81 | 17.45 | 15.58 | 19.42 | 17.91 | 16.38 | 18.34 | 22.83 | 23.29 | 24.87 | 13.34 | 24.17 |
| Inventory | 18.01B | 16.83B | 14.96B | 16.12B | 15.64B | 14.59B | 13.2B | 12.82B | 12.31B | 11.3B | 10.62B | 9.21B | 8.27B | 8.37B | 7.86B | 7.33B | 6.36B | 6.83B | 6.77B | 7.38B | 7.49B | 7.25B | 7.47B | 7.62B | 7.36B | 6.29B | 4.66B | 2.94B | 2.61B | 1.44B | 1.27B |
| Days Inventory Outstanding | 27.42 | 28.65 | 24.88 | 29.7 | 32.64 | 34.21 | 32.98 | 33.74 | 34.66 | 33.42 | 33.69 | 34.72 | 35.11 | 31.78 | 27.86 | 27.18 | 24.49 | 27.04 | 29.54 | 33.02 | 36.54 | 38.79 | 45.54 | 53.25 | 57.06 | 51.75 | 48.22 | 48.23 | 51.19 | 32.43 | 55.08 |
| Other Current Assets | 2.47B | 2.43B | 2.71B | 72M | 0 | 1.1B | 0 | 0 | 756M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.19B | 264.2M | 354.8M | 3.03B | 1.05B | 262.5M | 341.9M | 218.3M | 236.3M | 851.1M | 473.1M | 368.4M | 135.6M | 155.1M |
| Total Non-Current Assets | 18.63B | 16.75B | 10.24B | 9.61B | 10.94B | 13.4B | 14.83B | 15.22B | 15.4B | 11.77B | 12.17B | 8.39B | 8.09B | 8.05B | 6.75B | 6.53B | 5.07B | 4.14B | 9.17B | 8.61B | 6.86B | 8.31B | 8.31B | 5.27B | 4.53B | 3.93B | 3.58B | 3.2B | 2.69B | 604.7M | 480.9M |
| Property, Plant & Equipment | 2.93B | 2.86B | 2.53B | 2.46B | 2.36B | 2.36B | 2.37B | 2.36B | 2.49B | 1.88B | 1.8B | 1.51B | 1.46B | 1.49B | 1.55B | 1.51B | 1.47B | 1.46B | 1.74B | 1.65B | 1.5B | 2.48B | 2.36B | 2.09B | 1.89B | 1.84B | 1.73B | 1.56B | 1.47B | 277.5M | 166.9M |
| Fixed Asset Turnover | 87.19x | 77.88x | 89.69x | 83.29x | 76.80x | 68.84x | 64.63x | 61.77x | 55.01x | 69.17x | 67.68x | 68.08x | 62.43x | 67.89x | 69.34x | 67.88x | 67.06x | 65.55x | 50.32x | 52.73x | 52.93x | 29.25x | 27.29x | 27.15x | 26.99x | 26.08x | 22.19x | 16.08x | 14.36x | 66.28x | 55.40x |
| Goodwill | 13.7B | 9.69B | 4.72B | 4.61B | 5.86B | 7.99B | 8.36B | 8.38B | 8.32B | 7.22B | 7.17B | 5.07B | 4.88B | 4.6B | 3.98B | 3.85B | 2.25B | 2.27B | 6.16B | 5.86B | 4.28B | 4.84B | 0 | 0 | 0 | 1.18B | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 2.49B | 1.73B | 1.47B | 1.77B | 2.1B | 2.92B | 3.43B | 3.91B | 1.99B | 2.26B | 948M | 992M | 973M | 414M | 413M | 0 | 0 | 0 | 0 | 0 | 0 | 4.94B | 2.33B | 1.54B | 0 | 1.04B | 942.1M | 850.5M | 122.1M | 114.9M |
| Long-Term Investments | 14M | 14M | 43M | 56M | 77M | 68M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 691.5M | 0 | 916.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2B | 1.7B | 1.22B | 1.01B | 876M | 883M | 1.19B | 1.05B | 682M | 681M | 944M | 866M | 765M | 986M | 807M | 759M | 657.8M | 405.7M | 384.1M | 1.1B | 1.07B | 1.02B | 1.01B | 846.1M | 1.09B | 912.4M | 805.7M | 700.3M | 373.7M | 205.1M | 199.1M |
| Total Assets | 56.69B | 53.12B | 45.12B | 43.35B | 43.88B | 44.45B | 40.77B | 40.96B | 39.95B | 40.11B | 34.12B | 30.14B | 26.03B | 25.82B | 24.26B | 22.85B | 19.99B | 25.12B | 23.45B | 23.15B | 23.37B | 22.06B | 21.37B | 18.52B | 16.44B | 14.64B | 12.02B | 8.4B | 7.48B | 3.09B | 2.83B |
| Asset Turnover | 4.49x | 4.19x | 5.03x | 4.73x | 4.13x | 3.65x | 3.75x | 3.55x | 3.42x | 3.24x | 3.56x | 3.40x | 3.50x | 3.92x | 4.43x | 4.49x | 4.93x | 3.82x | 3.73x | 3.75x | 3.41x | 3.29x | 3.02x | 3.06x | 3.11x | 3.27x | 3.19x | 2.99x | 2.82x | 5.95x | 3.27x |
| Asset Growth % | 83.24% | 17.73% | 4.09% | -1.21% | -1.29% | 9.04% | -0.48% | 2.53% | -0.4% | 17.55% | 13.2% | 15.78% | 0.83% | 6.43% | 6.19% | 14.29% | -20.42% | 7.12% | 1.27% | -0.94% | 5.96% | 3.23% | 15.38% | 12.67% | 12.26% | 21.78% | 43.07% | 12.39% | 141.87% | 9.44% | 53.39% |
| Total Current Liabilities | 41.99B | 38.9B | 35.64B | 33.74B | 30.55B | 27.62B | 23.61B | 24.11B | 22.89B | 21.22B | 19.7B | 17.24B | 15.12B | 14.59B | 14.17B | 13.37B | 11.54B | 12.28B | 10.39B | 11.46B | 11.58B | 9.9B | 9.37B | 7.31B | 6.81B | 6.57B | 5.55B | 2.97B | 2.73B | 1.39B | 1.42B |
| Accounts Payable | 37.83B | 34.71B | 31.76B | 29.93B | 27.13B | 23.7B | 21.37B | 21.54B | 19.68B | 17.91B | 17.31B | 14.37B | 12.15B | 12.29B | 11.73B | 11.33B | 9.49B | 9.04B | 8.3B | 9.16B | 8.91B | 7.35B | 6.43B | 5.29B | 5.5B | 5.32B | 3.9B | 2.36B | 2.14B | 1.14B | 1.14B |
| Days Payables Outstanding | 56.12 | 59.09 | 52.83 | 55.15 | 56.63 | 55.56 | 53.42 | 56.67 | 55.41 | 52.95 | 54.93 | 54.17 | 51.61 | 46.66 | 41.55 | 42 | 36.59 | 35.78 | 36.24 | 40.98 | 43.44 | 39.34 | 39.21 | 36.95 | 42.67 | 43.8 | 40.33 | 38.78 | 42.06 | 25.65 | 49.27 |
| Short-Term Debt | 671M | 714M | 551M | 892M | 682M | 976M | 10M | 452M | 1B | 1.33B | 587M | 281M | 801M | 168M | 476M | 326.7M | 233.2M | 367.3M | 159M | 16M | 199M | 307.9M | 860.6M | 228.7M | 18.2M | 14.2M | 423.4M | 40.2M | 32M | 28.3M | 106M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.48B | -164M | 0 | 42M | 0 | 96M | 0 | 0 | 213M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.37B | 50M | 34.2M | 534.2M | 345.5M | 55.1M | 64.3M | 0 | 0 | 0 | 561.2M | 550.7M | 225.1M | 175.5M |
| Current Ratio | 0.91x | 0.94x | 0.98x | 1.00x | 1.08x | 1.12x | 1.10x | 1.07x | 1.07x | 1.34x | 1.11x | 1.26x | 1.19x | 1.22x | 1.24x | 1.22x | 1.29x | 1.71x | 1.37x | 1.27x | 1.43x | 1.37x | 1.39x | 1.81x | 1.75x | 1.63x | 1.52x | 1.75x | 1.76x | 1.79x | 1.65x |
| Quick Ratio | 0.48x | 0.50x | 0.56x | 0.52x | 0.57x | 0.60x | 0.54x | 0.54x | 0.53x | 0.80x | 0.58x | 0.73x | 0.64x | 0.64x | 0.68x | 0.67x | 0.74x | 1.15x | 0.72x | 0.62x | 0.78x | 0.63x | 0.60x | 0.77x | 0.67x | 0.67x | 0.68x | 0.76x | 0.80x | 0.76x | 0.75x |
| Cash Conversion Cycle | -8.91 | -8.73 | -8.51 | -5.67 | -2.73 | -0.9 | -0.71 | -1.74 | 0.06 | 3.07 | 1 | 3.78 | 5.06 | 7.88 | 7.88 | 7.08 | 7.06 | 11.09 | 14.13 | 11.86 | 10.55 | 15.04 | 25.75 | 34.22 | 30.77 | 26.29 | 30.72 | 32.74 | 34.01 | 20.12 | 29.98 |
| Total Non-Current Liabilities | 17.53B | 16.86B | 12.69B | 12.57B | 14.03B | 15.04B | 15.36B | 10.52B | 11B | 12.06B | 7.85B | 6.64B | 4.52B | 5.25B | 3.84B | 3.63B | 3.18B | 4.12B | 5.31B | 4.32B | 3.36B | 3.34B | 4.02B | 3.48B | 3.23B | 2.63B | 2.08B | 1.87B | 1.8B | 367.7M | 369.5M |
| Long-Term Debt | 8.24B | 7.82B | 4.58B | 3.85B | 4.69B | 5.32B | 6.76B | 7.58B | 8.01B | 9.07B | 4.95B | 5.21B | 3.17B | 3.69B | 2.42B | 2.17B | 1.9B | 3.28B | 3.69B | 3.46B | 2.59B | 2.32B | 2.83B | 2.47B | 2.21B | 1.87B | 1.52B | 1.22B | 1.33B | 277.8M | 265.1M |
| Capital Lease Obligations | 811M | 811M | 475M | 434M | 437M | 419M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 28.41B | 2.43B | 3.09B | 3.14B | 3.02B | 8.31B | 8.59B | 2.94B | 2.98B | 2.88B | 2.78B | 1.43B | 1.35B | 1.57B | 1.42B | 1.45B | 1.28B | 847.3M | 1.63B | 859.9M | 771.9M | 1.02B | 1.19B | 1.01B | 1.03B | 759.5M | 552.5M | 645.7M | 467.7M | 89.8M | 104.3M |
| Other Non-Current Liabilities | 160M | 5.8B | 4.54B | 5.14B | 5.89B | 981M | 0 | 0 | 12M | 118M | 117M | 0 | 0 | 0 | 0 | 0 | 0 | -8.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100K | 100K |
| Total Liabilities | 59.36B | 55.76B | 48.33B | 46.31B | 44.58B | 42.66B | 38.97B | 34.63B | 33.89B | 33.28B | 27.55B | 23.89B | 19.63B | 19.84B | 18.02B | 17B | 14.71B | 16.39B | 15.7B | 15.78B | 14.94B | 13.25B | 13.39B | 10.79B | 10.04B | 9.21B | 7.62B | 4.83B | 4.52B | 1.76B | 1.79B |
| Total Debt | 8.92B | 9.35B | 5.61B | 5.18B | 5.8B | 6.71B | 6.78B | 8.03B | 9.01B | 10.39B | 5.54B | 5.49B | 3.97B | 3.85B | 2.89B | 2.5B | 2.13B | 3.65B | 3.85B | 3.47B | 2.79B | 2.63B | 3.7B | 2.7B | 2.23B | 1.89B | 1.95B | 1.26B | 1.36B | 306.1M | 371.1M |
| Net Debt | 4.98B | 5.47B | 476M | 1.1B | 1.09B | 3.31B | 4B | 5.5B | 7.25B | 3.52B | 3.18B | 876M | 1.11B | 1.95B | 620M | 572.7M | -626M | 2.42B | 2.56B | 2.16B | 1.6B | 1.23B | 2.6B | 976.6M | 843.2M | 951.1M | 1.41B | 1.08B | 988.7M | 63M | 66.8M |
| Debt / Equity | -3.34x | - | - | - | - | 3.74x | 3.78x | 1.27x | 1.49x | 1.52x | 0.84x | 0.88x | 0.62x | 0.65x | 0.46x | 0.43x | 0.40x | 0.42x | 0.50x | 0.47x | 0.33x | 0.31x | 0.46x | 0.35x | 0.35x | 0.35x | 0.44x | 0.35x | 0.46x | 0.23x | 0.36x |
| Debt / EBITDA | 2.82x | 3.05x | 2.87x | 3.58x | 68.29x | 5.35x | - | 2.62x | 7.78x | 3.66x | 1.79x | 2.10x | 1.69x | 2.77x | 1.37x | 1.37x | 1.36x | 2.41x | 2.39x | 2.05x | 1.30x | 1.26x | 1.41x | 1.10x | 1.07x | 1.07x | 1.27x | 0.99x | 1.27x | 0.33x | 1.11x |
| Net Debt / EBITDA | 1.57x | 1.78x | 0.24x | 0.76x | 12.80x | 2.64x | - | 1.80x | 6.26x | 1.24x | 1.03x | 0.34x | 0.47x | 1.40x | 0.29x | 0.31x | -0.40x | 1.60x | 1.58x | 1.28x | 0.75x | 0.59x | 0.99x | 0.40x | 0.41x | 0.54x | 0.92x | 0.84x | 0.92x | 0.07x | 0.20x |
| Interest Coverage | 6.38x | 10.77x | 24.55x | 8.89x | -4.33x | 2.79x | -14.85x | 6.96x | 0.31x | 10.57x | 13.79x | 14.95x | 14.52x | 8.22x | 18.87x | 17.32x | 11.73x | 6.47x | 10.55x | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | -2.67B | -2.63B | -3.21B | -2.96B | -706M | 1.79B | 1.79B | 6.33B | 6.06B | 6.83B | 6.57B | 6.26B | 6.4B | 5.97B | 6.24B | 5.85B | 5.28B | 8.72B | 7.75B | 7.38B | 8.49B | 8.59B | 7.98B | 7.67B | 6.39B | 5.44B | 4.4B | 3.57B | 2.95B | 1.33B | 1.04B |
| Equity Growth % | 1.42% | 18% | -8.62% | -318.84% | -139.35% | 0.11% | -71.69% | 4.47% | -11.26% | 3.91% | 5.04% | -2.27% | 7.13% | -4.31% | 6.75% | 10.86% | -39.53% | 12.61% | 5.02% | -13.12% | -1.19% | 7.73% | 3.93% | 20.05% | 17.58% | 23.56% | 23.27% | 20.8% | 121.39% | 28.86% | 88.95% |
| Book Value per Share | -11.32 | -10.88 | -13.00 | -11.29 | -2.53 | 6.10 | 6.12 | 21.03 | 19.23 | 21.34 | 19.91 | 18.67 | 18.55 | 17.37 | 17.89 | 16.59 | 14.60 | 24.13 | 21.28 | 18.23 | 19.81 | 19.71 | 18.55 | 16.91 | 14.10 | 11.73 | 9.69 | 8.34 | 7.09 | 5.60 | 4.49 |
| Total Shareholders' Equity | -2.83B | -2.78B | -3.21B | -2.96B | -709M | 1.79B | 1.79B | 6.33B | 6.06B | 6.81B | 6.55B | 6.26B | 6.4B | 5.97B | 6.24B | 5.85B | 5.28B | 8.72B | 7.75B | 7.38B | 8.49B | 8.59B | 7.98B | 7.67B | 6.39B | 5.44B | 4.4B | 3.57B | 2.95B | 1.33B | 1.04B |
| Common Stock | -7.22B | 2.96B | 2.92B | 2.75B | 2.81B | 2.81B | 2.79B | 2.76B | 2.73B | 2.7B | 3.01B | 3B | 2.98B | 2.95B | 2.93B | 2.9B | 0 | 0 | 0 | 0 | 0 | 2.77B | 2.65B | 2.4B | 2.11B | 1.89B | 1.51B | 1.09B | 1.06B | 0 | 0 |
| Retained Earnings | 1.73B | 783M | -286M | -642M | -280M | 1.21B | 1.17B | 5.43B | 4.64B | 4.97B | 6.42B | 5.52B | 4.77B | 4.04B | 4.09B | 3.33B | 2.65B | 5.95B | 5.02B | 11.54B | 9.76B | 8.87B | 7.89B | 6.47B | 5.16B | 4.15B | 3.33B | 2.54B | 2.01B | 701.9M | 492.8M |
| Treasury Stock | 0 | -6.37B | -5.68B | -4.91B | -3.13B | -2.19B | -2.07B | -1.79B | -1.22B | -731M | -2.76B | -2.25B | -1.42B | -1.08B | -816M | -457.7M | -331M | -343M | -480.7M | -8.22B | -4.5B | -3.04B | -2.59B | -1.14B | -737M | -457.2M | -346.6M | -17.2M | -82.3M | 0 | 0 |
| Accumulated OCI | -161M | -155M | -167M | -151M | -114M | -34M | -104M | -79M | -92M | -125M | -116M | -23M | 70M | 68M | 37M | 77M | 70M | 82.2M | 210.8M | 121M | 33.9M | -3.1M | 22.6M | -58.6M | -131.3M | -144.8M | -94.3M | -49M | -33.3M | 0 | 0 |
| Minority Interest | 160M | 147M | 1M | 1M | 3M | 3M | 3M | 2M | 0 | 20M | 17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Negative equity and goodwill
As reported in recent financial filings, Cardinal Health's equity position has remained consistently negative over the last ten quarters, bottoming at -$3.4 billion in 2026Q2 and currently sitting at -$2.8 billion, which suggests a structural imbalance between total assets and the company's mounting liabilities.
The persistent negative equity indicates that the company's historical accounting decisions and capital allocation strategies have eroded the book value of the firm. Investors should monitor whether this trend reflects aggressive share repurchases or the cumulative impact of impairment charges and litigation-related liabilities that continue to weigh on the balance sheet.
Based on the company's quarterly balance sheets, goodwill has expanded significantly from $4.0 billion in 2024Q2 to $13.7 billion by 2026Q3, representing a substantial portion of the $56.7 billion in total assets and highlighting a heavy reliance on inorganic growth to drive the business model.
This rapid accumulation of goodwill warrants further investigation into the underlying performance of acquired assets, as it increases the risk of future impairment charges if these units fail to meet return thresholds. The concentration of intangible assets relative to tangible infrastructure suggests that the firm's asset base is increasingly sensitive to valuation adjustments.
According to the provided quarterly data, the current ratio has hovered narrowly between 0.91 and 1.02 over the past ten quarters, indicating that the company maintains a razor-thin liquidity buffer relative to its short-term obligations in the capital-intensive pharmaceutical distribution industry.
A current ratio consistently near or below 1.0 suggests that the firm relies heavily on the rapid turnover of its inventory and the timely collection of receivables to meet its immediate financial commitments. This lack of a significant liquidity cushion may leave the company vulnerable to sudden disruptions in the healthcare supply chain or unexpected shifts in working capital requirements.
As indicated by the latest financial statements, total debt has increased from $4.7 billion in 2024Q2 to $8.9 billion in 2026Q3, reflecting a strategic shift toward higher leverage to fund operations and acquisitions despite the company's already strained equity position.
The escalation in debt levels appears to be a necessity-driven response to support the firm's massive scale and ongoing transformation initiatives. Investors should monitor the interest coverage implications of this rising debt burden, especially given the low-margin nature of the distribution business which provides little room for error in servicing these obligations.
Quick answers to the most common questions about buying CAH stock.
As of 2025, Cardinal Health, Inc. (CAH) had total assets of $53.12B including $36.37B in current assets.
Cardinal Health, Inc. (CAH) carries total debt of $9.35B, offset by $3.87B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Cardinal Health, Inc. (CAH) has total shareholders' equity (book value) of $-2781.0M ($-10.88 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Cardinal Health, Inc. (CAH) reported a current ratio of 0.94x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.